<DOC>
	<DOC>NCT02265367</DOC>
	<brief_summary>The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.</brief_summary>
	<brief_title>Novel Medication as a Potential Smoking Cessation Aid</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Be between 25 years old and 55 years old Smoke a minimum number of cigarettes per day Indicate motivation to quit smoking Current or history of medical or psychiatric conditions that could interfere with measures being studied or that could be affected by the study medication Use of medication that could interfere with measures to be studied or that could be expected to interact with levomilnacipran Are pregnant or breast feeding The investigators will evaluate if there are other reasons why someone may not be eligible to participate</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>